Field of View for Gamma Ray Detectors and Extended

Radiation Sources
To the Editor: In their recent article, Anderson et al. (1987) elegantly make use of the fact that the size of the field of view, from which cerebral blood flow (CBF) is measured by the classical inert gas clearance technique with external radiation moni toring, is essentially determined by the choice of the radioisotope and the size, type, and collimation of the radiation detector. They used the two radio isotopes-xenon-133, a gamma emitter for prac tical purposes, and krypton-85, a beta emitter-to measure CBF in cat and rabbit brain. The detectors used were either a conventional NaI(TI) scintilla tion detector or a miniature solid state CdTe device for xenon-133 detection, and a Geiger-Mueller tube for krypton-85.
Our comments are related to the way the authors characterize the field of view from which CBF is measured with xenon-133. We agree that for krypton-85, due to the "self-absorption" of the beta particles, only the activity from a discrete tissue volume of approximately 1.0 mm in depth is recorded. We believe, however, that in the case of xenon-133. the statements that the NaI(TI) detector measures a volume of 74 mm3 at the 90% isore sponse level and that the counting volume of the CdTe device is 5 mm3 at its 90% isoresponse level might convey to the reader who is less familiar with the field the erroneous impression that a major por tion (90%) of the detected radioactivity is derived from a very small volume of tissue. We believe that this was not the intention of the authors, since they themselves have pointed out the limited spatial res olution capability of external single gamma detec tion for CBF measurement (Hanson et aI., 1975) . A few clarifying comments might therefore be in order.
Although isoresponse curves are useful to de scribe a detector's response to a point source, their usefulness in the case of an extended source such as a cerebral hemisphere injected with xenon-133 is very limited and often misleading. In our Institute, we have used xenon-133 and krypton-85 in the past to measure CBF in dogs (Soejima et aI., 1979) . In order to estimate the size of the field of view from which CBF was measured with the two isotopes, we carried out phantom studies with extended 144 sources approximating the experimental situation (Meyer, 1980) . We used a Si(Li) solid state detector (Hohberger et aI., 1975) similar to the CdTe device used by Anderson et al. (1987) , and the lower level of the energy discriminator was also set at 75 keY.
We found that for a uniform xenon-133 source, 90 mm x 90 mm and 50 mm deep, 90% of the total number of counts originated from a volume ex tending from the surface to a depth of 30 mm. The large count rate contribution from relatively distant tissue layers may be understood if one realizes that in an idealized situation with negligible absorption, the number of counts recorded by an uncollimated detector from hemispherical layers of an extended radiation source is independent of the radial dis tance of these layers (shells) from the detector (the inverse square law response for a point source is offset by the source volume seen by the detector which increases proportionally to the square of the radial distance of each layer). The above-men tioned experimental figures changed only slightly when we assumed that the cortical layer of the brain contained three to five times the activity con centration of the deeper white matter layers, re flecting the CBF ratio between these two cerebral components. Collimation of the detector will re strict its field of view laterally, but it does not re duce its depth response (look-through phenom enon) (Hanson et aI., 1975) , We therefore suggest that the tissue volume from which 90% of the total counts are recorded is considerably larger than 5 mm3 for the CdTe device and more than 74 mm3 for the NaI(Tl) detector. We hope that these construc tive comments may contribute to the understanding and clarification of this interesting methodological Issue. 
